- Anemia Outcomes from a Medical-Assistant Driven Anemia Protocol to Treat Patients and Move Toward Monthly Epoetin Dosing.
Topf, J., Abud, G., Maria, V., Provenzano, R., Anemia
Outcomes from a Medical-Assistant Driven Anemia Protocol to Treat Patients and
Move Toward Monthly Epoetin Dosing. American Society of Nephrology, Philadelphia, PA,
2005.
- Positional Differences in Blood Pressure (BP) in Women
Babbar, N., Steigerwalt, S., Positional Differences in Blood Pressure (BP) in
Women. American Society of
Hypertension 20th Annual Meeting, San Francisco, CA, 2005.
- Adequacy of Blood Pressure Management in our Hypertensive Type 2 Diabetic Outpatient Population
Abboud, J., Castillo, V., Steigerwalt, S., Adequacy of Blood Pressure
Management in our Hypertensive Type 2 Diabetic Outpatient Population.
American Society of Hypertension 20th Annual Meeting, San Francisco, CA, 2005.
- Do Cognitive Representations of Medication Behaviors Modify the Impact of Interventions for Blood Pressure Reduction in Women?
Steigerwalt, S., Scisney-Matlock, M., Do Cognitive Representations of
Medication Behaviors Modify the Impact of Interventions for Blood Pressure
Reduction in Women? American Society of Hypertension 20th Annual
Meeting, San Francisco,
CA, 2005.
- Safety and Efficacy of Steroid Avoidance and Calcineurin Withdrawal in Recipients of Living Unrelated Renal Allograft (LURA).
El-Ghoroury, M., Nagrecha, N., Safety and Efficacy of Steroid Avoidance and Calcineurin
Withdrawal in Recipients of Living Unrelated Renal Allograft
(LURA). National Kidney Foundation
Spring Clinical Meeting, Washington, D.C., 2005.
- Steroid Avoidance and Calcineurin Inhibitor (CI) Minimization in Recipients of Cadaveric Donor Renal Allograft (CRA): A Comparative Study
Nagrecha, N., El-Ghoroury, M., Steroid Avoidance and Calcineurin Inhibitor
(CI) Minimization in Recipients of Cadaveric Donor Renal Allograft (CRA): A
Comparative Study. National Kidney Foundation Spring Clinical Meeting,
Washington, D.C., 2005.
- The Role of Home Blood Pressure Monitoring (HBPM) in the Control of Hypertension in Renal Transplant Recipients
Awosika, B., Makos, G., Steigerwalt, S., El-Ghoroury, M., Provenzano, R., The
Role of Home Blood Pressure Monitoring (HBPM) in the Control of Hypertension in
Renal Transplant Recipients. American Society of Transplantation, Boston, MA, 2004.
- Long Term AV Graft Survival of Polyurethane (Vectra®) Grafts.
Rankin, S., Provenzano,
R., Flynn, L., Long Term AV
Graft Survival of Polyurethane (Vectra®) Grafts. American Society of
Nephrology, San Diego,
CA, 2003.
- Safety and Efficacy of Sirolimus, Low Dose Tacrolimus and Early Steroid Withdrawal in Patients with Cadaveric Renal Allographs: A Comparative Study
Nagrecha, N., El-Ghoroury, M., Provenzano, R., Safety and Efficacy of
Sirolimus, Low Dose Tacrolimus and Early Steroid Withdrawal in Patients with
Cadaveric Renal Allographs: A Comparative Study. American Society of
Nephrology Meeting, St.
Louis, MO, 2004.
- Incidence and Risk Factors of Nocardiosis in Renal Transplant Recipients
Pasumarthy, A., Rankin, S., El-Ghoroury, M., Johnson, L.B., Provenzano,
R., Incidence and Risk Factors of Nocardiosis in Renal
Transplant Recipients. American Society of Nephrology, San Diego, CA, 2003.
- Extended Dosing of PROCRIT (Epoetin Alfa) Effectively Treats Anemia and Improves Quality of Life in Patients with Diabetes and CKD
Provenzano, R., Extended Dosing of Procrit (Epoetin Alfa) Effectively Treats
Anemia and Improves Quality of Life in Patients with Diabetes and CKD.
National Kidney Foundation Clinical Meetings, Chicago, IL,
2004.
- Benign Course of Hypocomplementic Mesangiaoproliferative Glomerulo-nephritis
Nagrecha, N., Saberi, M., Benign Course of Hypocomplementic
Mesangiaoproliferative Glomerulo-nephritis. National Kidney Foundation
Clinical Meetings, Chicago,
IL, 2004.
- Prospective, Randomized Evaluation of Extended Epoetin Alfa Dosing for Treatment of Anemia of Chronic Kidney Disease (CKD): PROMPT Interim Analysis
Provenzano, R., Bhaduri, S., Tang, K.L., Klausner, M., Singh, A.,
Prospective, Randomized Evaluation of Extended Epoetin Alfa Dosing for
Treatment of Anemia of Chronic Kidney Disease (CKD): PROMPT Interim
Analysis. American Society of Nephrology, San Diego, CA,
2003.
- Cigarette Smoking is a Predictor of Poorer Renal Survival in Diabetic Patients
Nagrecha, N., Crook, E., Cigarette Smoking is a Predictor of Poorer Renal
Survival in Diabetic Patients, National Kidney Foundation Clinical Meetings,
Chicago, IL, 2004.
- Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics
Jefic, D., Al-Sabbagh, R., Fadanelli, M., Steigerwalt, S., Low Prevalence of
Primary Aldosteronism in Hypertensive Diabetics. American Society of
Hypertension 19th Scientific Meeting , New York, NY,
May 2004.
- Microbiology Companion: A STUDY GUIDE FOR STUDENTS BY STUDENTS
Spiral-bound: 243 pages; Publisher: ALERT & ORIENTED PUBLISHING COMPANY; 2 edition (1994); ISBN-10: 0964012413; ISBN-13: 978-0964012417
- The Dinamap Dilemma: Inaccuracy of the Commonly used Dinamap 8100 Compared to Simultaneous Mercury Manometer Measurement in Hospitalized Patients at Different Levels of Blood Pressure
Parker, S., Steigerwalt, S., The Dinamap Dilemma: Inaccuracy of the Commonly
used Dinamap 8100 Compared to Simultaneous Mercury Manometer Measurement in
Hospitalized Patients at Different Levels of Blood Pressure. American
Society of Hypertension, New
York NY, 2004.
- Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics
Jefic, D., Al-Sabbagh, R., Fadanelli, M., Steigerwalt, S., Low Prevalence of
Primary Aldosteronism in Hypertensive Diabetics. American Society of
Hypertension, New York,
NY, 2004.
- Spironolactone Use Does Not Increase Serum Potassium in End Stage Renal Disease Patients on Hemodialysis.
Reddy, P., Steigerwalt, S., Brar, B., Provenzano, R., Spironolactone Use Does
Not Increase Serum Potassium in End Stage Renal Disease Patients on
Hemodialysis. American Society of Nephrology, San Diego, CA, 2003.
- Safety and Efficacy of Calcineurin and Steroid Avoidance in Living Donor Renal Allografts
Reddy, P., Brar, B., El-Ghoroury, M., Provenzano, R., Oh, H., Fasola, C.,
Safety and Efficacy of Calcineurin and Steroid Avoidance in Living Donor
Renal Allografts. American Society of Nephrology, San Diego, CA, 2003.
- Adequacy of Inpatient Versus Outpatient Hemodialysis in End Stage Renal Disease Patients: A Comparative Study.
Brar, B., Tayeb., J., Reddy, P., Goushaw, P., Provenzano, R., Adequacy of
Inpatient Versus Outpatient Hemodialysis in End Stage Renal Disease Patients: A
Comparative Study. American Society of Nephrology, San Diego, CA, 2003.
- Aldosterone Is Involved in Left Ventricular Hypertrophy in African American Males with End Stage Renal Disease Treated with Hemodialysis
Steigerwalt, S., Mesiha, N., Zafar, A., Gardin, J., Provenzano, R.,
Aldosterone Is Involved in Left Ventricular Hypertrophy in African American
Males with End Stage Renal Disease Treated with Hemodialysis. American
Society of Nephrology, San
Diego, CA, 2003.
- Once-Weekly (QW) Treatment with Epoetin Alfa in Patients with Anemia Due to Chronic Kidney Disease (CKD)
[
Article listing on pubMed.gov]
Provenzano, R., Morrison, L., Once-Weekly (QW) Treatment with Epoetin Alfa in Patients with
Anemia Due to Chronic Kidney Disease (CKD): Preliminary Analysis. J Am Soc Nephrol
2001:12:A1227.
OBJECTIVE: To describe the characteristics and prevalence of anemia in
patients with diabetes and chronic kidney disease (CKD) not receiving
dialysis and to evaluate the efficacy and safety of once-weekly (QW)
epoetin alfa for the treatment of anemia in these patients.
- An Analysis of Bone Disease-Related Medication Use Throughout ESRD.
Johnson, C., McCarthy, J., Tello, A., Provenzano, R., Deane, J. An Analysis of Bone
Disease-Related Medication Use Throughout ESRD. National Conference on
Dialysis, New Orleans,
LA, 2001
- Captopril renal scintigraphy in renovascular hypertension
by Quresh T. Khairullah, Douglas L. Somers, Recayi Aktay, American Family Physician, May 1, 1997
